Evidence map›Paper›PMID 42353284›Full record

ArticleInternational journal of molecular sciences2026

Amplicon-Based Multiregion Genomic Characterization of HIV-1 in a Tertiary-Care Hospital in Mexico: Antiretroviral Resistance Mutations and Subtype Diversity.

Eduardo García-Moncada, Enoc Mariano Cortés-Malagón, Jesús Alejandro Pineda-Migranas, Montserrat Ruiz Santana, Iliana Alejandra Cortés-Ortíz, José Francisco Escutia Domínguez, Daniel Agustín Bravata-Alcántara, Gustavo Acosta-Altamirano, Saúl David Razo-González, Manuel Alberto Castillo Mendez and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eduardo García-MoncadaMedical School, National Polytechnic Institute, Mexico City 11340, Mexico.ORCID 0000-0001-9817-6183
Enoc Mariano Cortés-MalagónResearch Division, Hospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0002-6240-3468
Jesús Alejandro Pineda-MigranasMedical School, National Polytechnic Institute, Mexico City 11340, Mexico.ORCID 0009-0002-6498-6684
Montserrat Ruiz SantanaUnidad de Investigación en Salud, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ixtapaluca 56530, Mexico.
Iliana Alejandra Cortés-OrtízLaboratorio de Genética y Diagnóstico Molecular, Hospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0001-9409-5896
José Francisco Escutia DomínguezFacultad de Estudios Superiores Cuautitlán, Campo 1, Universidad Nacional Autónoma de México (UNAM), Mexico City 54740, Mexico.ORCID 0009-0004-8954-3243
Daniel Agustín Bravata-AlcántaraNational School of Medicine and Homeopathy, National Polytechnic Institute, Av. Guillermo Massieu Helguera 239, Ticomán, Mexico City 07320, Mexico.ORCID 0009-0002-4508-5370
Gustavo Acosta-AltamiranoHospital General de México, Mexico City 06726, Mexico.
Saúl David Razo-GonzálezFacultad de Estudios Superiores Zaragoza, Campus 2, Universidad Nacional Autónoma de México (UNAM), Iztapalapa, Mexico City 09230, Mexico.
Manuel Alberto Castillo MendezAcademia de Nutrición, Plantel Cuautepec, Colegio de Ciencias y Humanidades, Universidad Autónoma de la Ciudad de México, La Palma, Mexico City 07160, Mexico.
Mónica Sierra-MartínezUnidad de Investigación en Salud, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ixtapaluca 56530, Mexico.ORCID 0000-0002-1006-592X
Juan Carlos Bravata-AlcántaraUnidad de Investigación en Salud, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ixtapaluca 56530, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus type 1 exhibits extensive genetic diversity, which has important implications for molecular epidemiology, recombinant-pattern assessment, and antiretroviral resistance surveillance. In Mexico, HIV-1 molecular surveillance has historically relied mainly on partial

Indexed as

Drug Resistance, ViralHIV-1HIV InfectionsMutationAdultAnti-HIV AgentsFemaleGenetic VariationGenome, ViralGenomicsGenotypeHigh-Throughput Nucleotide SequencingHumansMaleMexicoMiddle AgedAnti-HIV Agentsamplicon-based sequencingBF recombinantscirculating recombinant formsDeepChekgenomic surveillanceHIV-1 molecular epidemiologyMexicotransmitted drug resistance

Identifiers

PMID42353284
PMCPMC13299566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.